Does the absence of breast arterial calcification (BAC 0) rule out severe coronary artery disease? A computed

Johannes Deeg1, Michael Swoboda1, Valentin Bilgeri2

  • 1Department of Radiology, Innsbruck Medical University, Innsbruck, Austria.

Insights

Breast arterial calcifications (BAC) do not rule out significant coronary artery disease in women over 55. BAC is not a reliable indicator for obstructive disease or high-risk plaques in symptomatic patients across all age groups.

Area of Science:

  • Cardiology
  • Radiology
  • Women's Health

Background:

  • Cardiovascular risk stratification in women is challenging, with current models underestimating risk.
  • Breast arterial calcifications (BAC) are independent prognosticators, but their role alongside coronary artery disease (CAD) profiles is debated.
  • The prognostic value of BAC, particularly in relation to coronary computed tomography (CT) findings, requires clarification.

Purpose of the Study:

  • To investigate the interaction between BAC and coronary CT outcomes.
  • To assess the relationship of BAC with coronary artery calcium (CAC) score, coronary stenosis severity, and high-risk plaque (HRP).

Main Methods:

  • Retrospective analysis of consecutive patients undergoing both mammography (MG) and coronary CT angiography (CTA).
  • Patients were stratified into three age groups: <55, 55-65, and >65 years.
  • Comparison of BAC prevalence with CAC score, obstructive CAD (>50% stenosis), and HRP presence.

Main Results:

  • Significant age-related differences were observed in BAC prevalence, high CAC (>300 AU), and obstructive CAD.
  • High CAC was rare in women <55 with BAC (0.82%) but more frequent in older groups (12.1% in 55-65, 8.4% in >65).
  • Obstructive CAD was present in 18.2% of women with BAC, increasing with age (10.7% vs. 14.7% vs. 29.9%). BAC showed weak correlation with CAC and CAD-RADS and no association with HRP.

Conclusions:

  • BAC can help rule out severe CAC (>300 AU) only in women under 55.
  • BAC does not rule out obstructive CAD or high-risk plaques in symptomatic women across any age group.
  • These findings have implications for primary prevention strategies in women based on age and BAC presence.
Abstract